63 results
Page 2 of 4
8-K
EX-99.1
npni0jg
4 May 23
Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
4:06pm
8-K
EX-10.1
y3qsps qz2lo
1 May 23
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
rjbe1c5xu0
19 Apr 23
Developing disease-modifying medicines for degenerative disorders Analyst Breakfast April 2023
7:30am
8-K
EX-10.1
zpokwnu5hb zv
23 Dec 22
Entry into a Material Definitive Agreement
4:24pm
S-3
jpnu00evykw1hqip
23 Dec 22
Shelf registration
4:16pm
S-3
EX-1.2
6mhe3rz1ol7dm
23 Dec 22
Shelf registration
4:16pm
8-K
EX-99.1
w6oohmt
16 Nov 22
Developing disease - modifying medicines for degenerative disorders November 2022
5:18pm
8-K
EX-1.1
p8wjet inzteeym
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.1
7coa38ht
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
8-K
EX-99.2
c1u5sm8eeiu0dne
14 Nov 22
Cognition Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
8:00am
424B4
nsa0egvf50 vfoi
14 Nov 22
Prospectus supplement with pricing info
6:02am
DRS
1im3itr
20 Oct 22
Draft registration statement
12:00am
8-K
EX-99.1
9j3kc3qc
29 Aug 22
Developing disease- modifying medicines for degenerative disorders August 2022
6:36am
8-K
EX-99.1
tis25qr3
9 Aug 22
Cognition Therapeutics Reports Second Quarter 2022 Financial Results and Provides Business Update
7:15am